Arkolith/Insider Trading/URGN/Form 4

Smith Jason Drew

General CounselUroGen Pharma Ltd. (URGN) · full profile →Form 4 · filed Jul 30, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$144K
Net Open-Market Flow
-$144K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 28, 2025Sell(S)8K$19.14$144K41K
Jul 28, 2025Option exercise(M)17K——49K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-25-023963) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML